Treatments differ widely in these mimics
Why precise diagnosis matters
How to tell the difference and why it matters
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Findings from a recent randomized trial investigating mepolizumab
A better outlook
Two trials provide important advances in treatment
An important goal of the Center for Vasculitis Care and Research
Research Points to Antibodies as Potential Marker
Advertisement
Advertisement